EON Network: October 2026 Newsletter |
The EON Network monthly newsletter shares upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications that may be of interest, and resources. This information is also available on the EON Network webpage. Past newsletters are archived.
Opportunities such as training workshops, publication submissions, and funding applications are great to share with the EON Network. We invite all to submit relevant opportunities by emailing eonnetwork@bsc.gwu.edu!
|
|
|
|
Wednesday, October 21 | 3:00 - 4:00 PM EST
|
|
|
|
| Diet and Chemotherapy-Induced Peripheral Neuropathy: Emerging Evidence, Future Directions
|
Chemotherapy-induced peripheral neuropathy (CIPN) is a significant side effect of certain types of chemotherapies that impacts quality of life and treatment tolerance. Emerging observational evidence has highlighted the relationship between diet and the development and reduction of CIPN. This presentation will discuss this existing body of evidence and the mechanisms by which diet may impact CIPN, particularly CIPN caused by platinum-based chemotherapies. This presentation will also present an upcoming randomized control trial investigating diet to delay CIPN development and explore future directions.
This EON webinar awards 1.0 CPEU for Commission on Dietetic Registration (CDR) credentialed practitioners in accordance with the Commission on Dietetic Registration’s CPEU Prior Approval Program.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.
|
|
|
|
December 2026 EON Webinar
|
Wednesday, December 2 | 2:00 - 3:00 PM EST
|
|
|
|
The GLP-1 Era in Cancer Care: From Emerging Evidence to Clinical Practice
|
This presentation will examine the evolving role of GLP-1 receptor agonists in cancer care, including proposed direct and indirect mechanisms through which they may influence cancer biology and health outcomes. It will review observational evidence and emerging clinical trials across cancer types, discuss implications for clinical practice, and identify key unanswered questions and priorities for future oncology research.
The George Washington University School of Medicine and Health Sciences is pending approval for this live activity to offer a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.
|
|
| |
|
- February 11, 2027 | 3:00 - 4:00 PM EST
|
- April 21, 2027 | 2:00 - 3:00 PM EST
|
|
|
|
|
Cho E, Compton SLE, Yang S, Tejani MA, Zakari A, Brown JC, Spielmann G. The impact of aerobic exercise on circulating T-cells and NK-cells in colorectal cancer survivors: a secondary analysis of a randomized trial. Cancer Control 2026 Jan-Dec;33:10732748261493127. Epub 2026 Sep 29. PMID: 42808444
|
"Aerobic exercise improves disease free and overall survival in colorectal cancer, but the biology behind this benefit remains unclear. In this secondary analysis of the EXACT trial, 60 survivors of stage I to III colorectal cancer were randomized to 12 weeks of home based, moderate intensity aerobic exercise or usual care. Using spectral flow cytometry and multiplex immunoassays, we examined circulating inflammatory markers alongside T cell and NK cell phenotypes. Exercise lowered soluble CD30, a marker of chronic T cell activation, and increased the proportion of NK cells expressing the activating receptor NKG2C, particularly within the CD56 bright subset. Resting T cell differentiation subsets did not change. The associations between inflammatory markers and naive or terminally differentiated CD8 T cells observed in the control group were not seen in the exercise group, suggesting that exercise may uncouple chronic inflammation from T cell aging. These exploratory findings point to immune remodeling as one plausible pathway through which exercise may improve survival and support larger trials linking immune changes to clinical outcomes."
|
|
|
|
Additional Publications of Interest
|
Foster BM, Miller MF, Spees CK, Thomson CA, Trujillo EB, Fortune EE, Fay L, Adintori PA, Stubbins R, Hamilton-Reeves JM. Nutrition services in oncology: a cross-sectional survey of patient experiences, needs, and gaps in care. J Acad Nutr Diet 2026;126(10):156395. PMID: 42320621
Engelen MP, Ford KL, Porter Starr KN, Sawyer MB, Bales CW, Siervo M, Schuetz P, Prado CM, Deutz NE. Inflammation hinders anabolic potential of nutritional support in cancer: findings from the Protein Recommendation to Increase Muscle (PRIMe) trial. Am J Clin Nutr 2026 Oct;124(4):101467. Epub 2026 Aug 10. PMID: 42575283
Loh KP, Jensen-Battaglia M, Marinac CR, Melvin A, Castro F, Skinner T, Normann AJ, Shah UA, Dieli-Conwright CM. Exercise and nutrition in hematologic malignancies: translational evidence and emerging interventions. Blood Neoplasia 2026 Jun 25;3(4):100262. PMID: 42718852
Kamiya N, Imai Y, Saigusa Y, Matsunaga R, Kawano A, Mogami T, Takagi K, Hayashi K, Tachibana K, Sakuma F, Matsunaga T, Nonogaki M, Nakamura T, Miyagi E, Mizushima T. Feasibility of an exercise intervention for chemotherapy-related fatigue in patients with gynecologic cancer: a randomized controlled trial with multidimensional assessment. BMC Sports Sci Med Rehabil 2026;18(1):423. PMID: 42745294
Garcia C, Leão I, Pinto D, Rato ND, Campolargo A, Dias I, Monteiro AR, Soares AM, Basto R, Dias E, Vilela E, Teixeira M, Coimbra E, Oliveira P, Amarelo A, Capela A, Viamonte S, Costa H, Joaquim A, Ribeiro F, Alves AJ. Exercise prehabilitation in head and neck cancer patients proposed for definitive chemoradiotherapy: The FIT4TREAT randomized controlled trial. Oral Oncol 2026 Oct;181:108119. PMID: 42673774
Dias Rato N, Garcia C, Pinto D, Guedes H, Joaquim A, Viamonte S, Helguero L, Viana J, Alves A. Exercise and pathologic complete response to cancer treatment: a systematic review and meta-analysis. Support Care Cancer 2026 Sep 9;34(10):948. PMID: 42714641
Nadler MB, Booth CM. Exercise oncology: from trials and guidelines to routine clinical care. Lancet Oncol 2026 Sep 4:S1470-2045(26)00386-4. PMID: 42697216
Shida D. Exercise as a disease-modifying therapy in colon cancer: practice-changing evidence from the CHALLENGE trial. Cancers (Basel) 2026;18(17):2883. PMID: 42738403
Zhang GQ, Ma C, Yang VB, Shi Q, Nowak JA, Pederson L, Twombly T, Väyrynen JP, Zhao M, Takashima Y, Shergill A, Kumar P, Couture F, Kuebler JP, Krishnamurthi S, Tan B, O'Reilly EM, Ogino S, Goldberg JE, Brown JC, Jurdi A, Shields AF, Meyerhardt JA. Physical activity and molecular residual disease in stage III colon cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80702. J Natl Cancer Inst 2026 Sep 24:djag342. Epub ahead of print. PMID: 42786576
Hasegawa M, Momma T, Kimura S, Ichinose H, Yago H, Sato T, Ito M, Matsumoto T, Ujiie D, Chida S, Okayama H, Saito M, Sakamoto W, Kono K. Longitudinal changes in nutritional, inflammatory, and CT-derived body composition markers during adjuvant chemotherapy for stage II/III colorectal cancer. Cancers (Basel) 2026;18(17):2886. PMID: 42738406
Negri Jimenez AL, Werts-Pelters SJ, Schmitz KH. Association between malnutrition and therapy intolerance in cancer patients: an observational cohort study. J Acad Nutr Diet 2026 Sep 23:156889. Epub ahead of print. PMID: 42777809
|
|
|
|
AICR/WCRF Grants Programme now open
|
The American Institute for Cancer Research is pleased to announce that from October 2026, AICR will be funding grants collaboratively within the WCRF Network. WCRF International will administer both calls on behalf of AICR, World Cancer Research Fund in the United Kingdom, and Wereld Kanker Onderzoek Fonds in the Netherlands.
WCRF International will accept applications to the Regular Grant Programme (including Investigator Initiated Grants and Pilot and Feasibility Grants) for senior established researchers, and the INSPIRE Research Challenge for early career researchers. Grants will be funded across the network and are open to all eligible researchers, regardless of geographic location.
The grant calls support original and innovative research into how diet, nutrition, physical activity, and body composition influence cancer prevention and survivorship, including outcomes during and after treatment.
Applications open: Monday 5 October 2026, 09:00 BST
Application deadline: Friday 13 November 2026, 17:00 GMT
For the 2026-27 calls, applications must address at least one of six research priority areas: integrative oncology, lifestyle and weight-loss medication, early-onset cancer, early-life exposures, ingested contaminants, ultra-processed foods. Sleep is also accepted within the Regular Grant Programme as a relevant modifiable exposure for the 2026-27 grant cycle.
Full details on eligibility, scope and how to apply are available on the Regular Grant Programme and INSPIRE Research Challenge webpages.
|
Call for Submissions: ASCO Educational Book
|
Submit your reviews and expert insights to ASCO Educational Book, an open access publication, welcoming year-round, uninvited submissions. Explore our 3 new article types: State of the Science, Clinical Connections, and Innovations in Oncology Education. Plus, now through December 31st, all submitted manuscripts will receive a 50% discount on the article processing charges.
|
|
|
|
Invitation to Submit Additional Opportunities
|
|
|
|
Opportunities such as training workshops, publication submissions, and funding applications are great to share with the EON Network. We invite all to submit relevant opportunities by emailing eonnetwork@bsc.gwu.edu!
|
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6710A Rockledge Drive, Suite 250 | Bethesda, MD 20817 US
|
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|